Skip to main content
. 2013 Mar 28;8(3):e60003. doi: 10.1371/journal.pone.0060003

Figure 3. Relationships between CSF biomarkers and clinical features.

Figure 3

(A–C) Age at onset and (D–F) disease duration (time from disease onset to death or to when the condition was confirmed) were compared between patients with and without (A, D) PrPSc protein or (B, E) 14-3-3 protein. In addition, (C, F) the correlation between these clinical features and the concentration of tau protein in CSF was examined for patients with the P102L, P105L, V180I, E200K, or M232R mutation.